Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most malignant tumors with persistently high morbidity and mortality. However, the expression, prognostic and clinical significance of FAM189 family genes in HCC remain largely unknown. In this study, the expression levels of FAM189 family genes in HCC we...

Full description

Bibliographic Details
Main Authors:	Wanshan Ma, Xiaoning Zhang, Chenchen Ma, Peng Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Pathology and Oncology Research
Subjects:	biomarker prognosis hepatocellular carcinoma clinical significance FAM189B
Online Access:	https://www.por-journal.com/articles/10.3389/pore.2022.1610674/full

Similar Items

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma
by: Meile Mo, et al.
Published: (2022-10-01)

Pan-Cancer Analysis of the Tumorigenic Effect and Prognostic Diagnostic Value of FAM111B in Human Carcinomas
by: Wu H, et al.
Published: (2023-05-01)

Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma
by: Junwei Wei, et al.
Published: (2021-11-01)

High FAM111B expression predicts aggressive clinicopathologic features and poor prognosis in ovarian cancer
by: Fang Wei, et al.
Published: (2023-06-01)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
by: Sarah Richtmann, et al.
Published: (2019-05-01)

FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma
by: Hui Gou, et al.
Published: (2023-09-01)

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
by: Lyu L, et al.
Published: (2020-12-01)

Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma
by: Guangji Chen, et al.
Published: (2022-06-01)

Immune implication of FAM83D gene in hepatocellular carcinoma
by: Tao Meng, et al.
Published: (2021-01-01)

Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma
by: Xiumei Wang, et al.
Published: (2018-11-01)

Loss of the Novel Mitochondrial Membrane Protein FAM210B Is Associated with Hepatocellular Carcinoma
by: Yuanqin Zhou, et al.
Published: (2023-04-01)

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
by: Xia Zheng, et al.
Published: (2021-10-01)

Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
by: Liang W, et al.
Published: (2022-12-01)

Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma
by: Qi Zhou, et al.
Published: (2022-11-01)

CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR‐630/HHIP axis
by: Mingshuang Lai, et al.
Published: (2023-06-01)

Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma
by: Jing Feng, et al.
Published: (2021-12-01)

Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
by: Sung Woo Ahn, et al.
Published: (2020-05-01)

AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study
by: Yan Liao, et al.
Published: (2021-02-01)

FAM21C Promotes Hepatocellular Carcinoma Invasion and Metastasis by Driving Actin Cytoskeleton Remodeling via Inhibiting Capping Ability of CAPZA1
by: Yao Lu, et al.
Published: (2022-01-01)

Individual and Co-Expression Patterns of FAM83H and SCRIB at Diagnosis Are Associated with the Survival of Colorectal Carcinoma Patients
by: Tae Young Jeong, et al.
Published: (2022-06-01)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
by: Peng Chen, et al.
Published: (2019-11-01)

Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma
by: Jin Zhang, et al.
Published: (2024-02-01)

High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma
by: Qi-Jia Zhang, et al.
Published: (2019-08-01)

Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI
by: Huang J, et al.
Published: (2021-12-01)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-09-01)

Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification
by: Lin S, et al.
Published: (2021-11-01)

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
by: Laizhu Zhang, et al.
Published: (2023-11-01)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
by: Wen-Jie Fan, et al.
Published: (2023-06-01)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01)

ncRNA-mediated upregulation of FAM83A is associated with poor prognosis and immune infiltration in pancreatic cancer
by: Wenbo Zou, et al.
Published: (2023-03-01)

Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma
by: Shihan Chen, et al.
Published: (2020-06-01)

Unravelling the Intricate Roles of FAM111A and FAM111B: From Protease-Mediated Cellular Processes to Disease Implications
by: Danielle Naicker, et al.
Published: (2024-02-01)

High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
by: Guoshun Zhang, et al.
Published: (2022-08-01)

Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo
by: Xudong Xie, et al.
Published: (2023-02-01)

FAM83H Expression Is Associated with Tumor-Infiltrating PD1-Positive Lymphocytes and Predicts the Survival of Breast Carcinoma Patients
by: Ji Eun Choi, et al.
Published: (2023-09-01)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
by: Jialiang Cai, et al.
Published: (2022-07-01)

Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
by: Wen-Jie Fan, et al.
Published: (2023-04-01)

Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinoma
by: Jia-Jia Dong, et al.
Published: (2019-02-01)

Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
by: Rujia Zhang, et al.
Published: (2023-12-01)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
by: Shun-Jun Fu, et al.
Published: (2018-08-01)